Application of (S,S)-Pentacycloundecane bis(4-Phenyloxazoline) as a Novel Chiral Ligand for Catalysis of the Asymmetric Diels-Alder Reaction of Cyclopentadiene with 3-Acryloyl-2-oxazolidinone by Arvidsson, PI et al.
Application of (S,S)-Pentacycloundecane
bis(4-Phenyloxazoline) as a Novel Chiral Ligand for
Catalysis of the Asymmetric Diels-Alder Reaction of
Cyclopentadiene with 3-Acryloyl-2-oxazolidinone
Per I. Arvidsson,a Thavendran Govender,b Hendrik G. Kruger,c* Glenn E.M. Maguirec and Tricia Naickerc
aDepartment of Biochemistry and Organic Chemistry, Uppsala University, Uppsala S-751 23, Sweden.
bSchool of Pharmacy and Pharmacology, University of KwaZulu-Natal, Westville Campus,
Private Bag X54001, Durban 4000, Republic of South Africa.
cSchool of Chemistry, University of KwaZulu-Natal, Westville Campus, Private Bag X54001, Durban 4000, Republic of South Africa.
Received 7 October 2008, revised 25 November 2008, accepted 18 December 2008.
ABSTRACT
The synthesis of the novel C1 symmetric (S,S)-pentacycloundecane bis(4-phenyloxazoline) ligand 5 and its evaluation as a chiral
Lewis acid catalyst in the benchmark asymmetric Diels-Alder reaction between 3-acryloyloxazolidin-2-one (6) and
cyclopentadiene (7) is reported. From the various metal salts screened the anhydrous magnesium perchlorate complex emerged
as the best catalyst. The endo-cycloadduct product 8 was afforded in 81% enantiomeric excess with an endo:exo ratio of 98:2. An
extensive screening of various metal ions as complexing agents was performed and is also reported.
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1. Introduction
There is enormous interest in the design and development of
efficient chiral ligands for asymmetric catalysis.1–3 In particular,
C2-symmetric bis(oxazoline) 1 ligand-metal complexes have
received attention because of their broad applicability in asym-
metric reactions.4,5 These ligands are derived from readily avail-
able chiral amino alcohols. The enantiocontrolling stereocentre
lies adjacent to the coordinating nitrogen of the oxazoline ring,
bringing the active metal in close proximity to the chiral centre.
These ligands therefore have a marked influence on the
stereochemical outcome of the reaction products.6 As a result,
various oxazoline-based ligands 1–4 incorporating a range of
heteroatoms, additional chiral elements and other structural
features have been employed in asymmetric catalysis.7 Our
research interests lie with the chemistry of pentacycloundecane
(PCU) cage compounds and attachment of the rigid cage to
chiral ligands.
The PCU cage renders the ‘faces’ of the ligand inherently
diastereotropically non-equivalent.8 We have employed the cage
previously as the central unit in our chiral ligands.9,10 Here we
have chosen the same design strategy by appending an
oxazoline moiety to each ‘arm’. The synthetic elucidation of
ligand 5 was recently reported.11 This PCU-oxazoline bidentate
ligand is one of a very few reported with C1 symmetry.
10,12,13 It also
offers a central ether oxygen which could potentially participate
in the binding of the metal, thus leading to a tridentate ligand
complex. Bis(oxazoline) catalyst complexes with this arrange-
ment have not been pursued to any large extent.7,14–17
Bis(oxazoline)-derived ligands are well known to function
as asymmetric Diels-Alder catalysts with alkenoyl imide
dienophiles. 3-Acryloyl and 3-crotonoyl cyclopentadiene are
used as the benchmark reactions to compare the efficiencies of
different catalysts in asymmetric Diels-Alder reactions.4 Herein
we report a novel bis(oxazoline)-derived chiral ligand having a
PCU framework. This new ligand was synthesized, complexed
to various metal salts and the resulting complex was applied as
an asymmetric Diels-Alder catalyst in the reaction of 3-acryloyl-
2-oxazolidinone (6) and cyclopentadiene (7) to yield the chiral
cycloadduct 8 (Scheme 1).
2. Results and Discussion
Synthesis of the novel PCU (S,S) bis(4-phenyloxazoline) ligand
5 follows the classical route involving the reaction of a diacid
derivative (in this case the PCU diacid) with an amino alcohol to
give the bis-amide intermediate; the latter is converted to the
bis-(oxazoline) in two steps.4,7 The PCU dione 9 was converted to
the 3,5-diallyl-4-oxahexacyclo[5.4.1.02,6.03,10.05,9.08,11]dodecane 10
as described previously.18,19 Ozonolysis of 10 followed by an
oxidative workup using formic acid and hydrogen peroxide
afforded the PCU diacid 11.18 To avoid competing reactions due
to the hydroxyl group on the amino alcohol it was decided to
protect the alcohol by using tertiary butyl dimethyl silyl chloride
(TBDMSiCl) to give (S)-N-(1-phenyl-2-tert-butyl-dimethylsilyl-
ethoxy) amine (12).20 This protecting group selectively protects
hydroxyl groups in the presence of primary amines. N,N-Dicy-
clohexylcarbodiimide (DDC)-promoted condensation of the
PCU diacid 11 with 12 afforded the protected PCU bis-amide 13
which was purified using column chromatography.21 The PCU
bis-amino alcohol 14 was obtained by deprotection of 13 with
tetra-N-butylammonium fluoride (TBAF) and purification was
again achieved using column chromatography.20 Cyclization
was obtained by the chlorination of 14 using thionyl chloride
to give the PCU bis-chloride 15, followed by treatment with
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aqueous sodium hydroxide4,15 to yield the PCU bis(4-phenyloxa-
zoline) derivative 5. The final product was isolated by column
chromatography in 80% yield from the PCU bis-amino alco-
hol 14 as shown in Scheme 2. The full NMR elucidation of the
novel compounds 13, 14 and 5 was recently published.11
Various alkaline earth and transition metals are known to com-
plex to bis(oxazoline)-derived ligands. A series of metals was
screened for the in situ formation of the catalyst complex from
ligand 5 (Table 1). The complexation procedure involved the
addition of an equimolar amount of the metal salt to a solution of
the ligand in dichloromethane.22 The resultant catalyst complex
was used to promote the described asymmetric Diels-Alder
reaction (Scheme 1).
From a range of metal salts evaluated, anhydrous Mg(ClO4)2
emerged as the best Lewis acid complex in terms of enantio-
selectivity (Table 1, entry 6). Magnesium bis(oxazoline) complexes
have been reported to display varying catalytic activity in Diels-
Alder reactions.15,23–26 Since anhydrous magnesium perchlorate
gave the highest enantiomeric excess it was decided to optimize
the solvent for this reaction. Substitution of the solvent CH2Cl2
with THF or CH3CN led to lower yields and enantioselectivities
(Table 2).
Once it was established that dichloromethane was the best
solvent, we next optimized the counterion on the metal-ligand
complex. Different magnesium salts were investigated to deter-
mine the effect of the counterion on the catalyst in the reaction
(Table 3). These results indicated that the enantiomeric excess
increased with increasing Lewis acidity of the metal in the order
Mg(OTf)2 < Mg(SbF6)2 < Mg(ClO4)2.
Once the optimum solvent and counterion were determined,
different loadings of the catalyst were investigated and 10 mol %
proved to be the best option (Table 4, entries 1, 2 and 4). The addi-
tion of molecular sieves to ensure strictly anhydrous conditions
did not affect the enantiomeric excess or yield of the reaction
(Table 4, entry 3). In order to evaluate the reaction temperature-
enantioselectivity profile, experiments at room temperature, 0
°C and –40 °C were carried out (Table 4, entries 6 and 7). As
expected for this reaction, the enantiomeric excess increased
with decreasing temperature. Experiments at temperatures
lower than –40 °C were impossible due to extremely low reaction
rates, therefore the reaction at –40 °C proved to yield the best
result with an enantiomeric excess of 81% (Table 4, entry 7).
It is important to note that the blank reaction (Table 1, entry 1)
takes place without any catalyst, albeit much slower. In order to
investigate to what extent the enantioselectivity is influenced by
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Scheme 1
Diels-Alder reaction of 3-acryloyloxazolidin-2-one (6) and cyclopentadiene (7).
the non-catalyzed reaction (racemic products form), the experi-
ment was performed with slow addition of cyclopentadiene
(Table 4, entry 5). From the data, it is clear that the enantio-
selectivity is not influenced by a concurrent non-catalyzed
racemic reaction.
From the metals screened (Table 1, entries 2 to 4), namely
calcium, zinc and copper, the corresponding products resulted
in excess of the (R)-enantiomer while the other metals gave rise
to excess of the (S)-enantiomer. According to the literature
bis(oxazoline) ligands are known sometimes to reverse the
chirality of 8 when zinc or copper are used.25,27–30 There are no
other reports on bis(oxazoline)-calcium complexes tested on
Diels-Alder type reactions, therefore a comparison with our
calcium result could not be made from the literature. The inver-
sion of chirality on the products when zinc or copper are used
was attributed to the different transition states experienced by
the complex as a result of changing the metal cation or substitu-
ents on the ligand.31 Corey et al.32 observed when magnesium
complexes of (R)-1 (R = Ph) were tested for this reaction that the
predominant product was the (S)-configuration. A tetrahedral
magnesium-bis(oxazoline) dienophile complex was proposed to
account for the observed asymmetric induction. Evans et al.29
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Scheme 2
Synthesis of ligand 5 from PCU dione 9.
proposed a square planar coordination for the copper complex
of (R)-1 (R = t-Bu), in which the product was the (R)-configuration
for the same Diels-Alder reaction. An interesting observation
occurred when both Evans’ and Corey’s ligands with the
(R)-configuration were complexed to magnesium. When the
counterion is perchlorate the product of the reaction is (S)-8, but
if two equivalents of water are added to the reaction the product
obtained is (R)-8.23 This stereochemical outcome was explained
by Desimoni et al. by establishing that water acts as an auxiliary
ligand which will expand the coordination number from four
(tetrahedral) to six (octahedral) when the counterion is perchlor-
ate.4,33,34 Since our best result was from Mg(ClO4)2 it was decided
to do a theoretical investigation to determine if the tetrahedral
complex form proposed in the literature is applicable in the
reaction investigated by us. Optimizations of the two possible
conformations of the magnesium complex of ligand 5 with the
substrate 6 were performed using density functional theory
(DFT) calculations. The first complex A has the unsaturated
bond of the dienophile 6 facing upwards while the second struc-
ture (complex B) has it facing downwards.
The geometry of both complexes is pentacoordinate. The
calculations revealed the distance between the magnesium ion
and imine nitrogens to be 2.18 Å and 2.11 Å. The distance
between the magnesium ion and carbonyl oxygen of the
dienophile is 2.01 Å. The ether oxygen on the PCU moiety also
participated in binding to the magnesium ion since the calcu-
lated metal to oxygen distance is 2.21 Å. It is therefore proposed
that the pentacoordinate system (Fig. 1) behaves similarly to the
octahedral complex suggested by Desimoni et al. This could
possibly explain the observation of no inversion occurring on
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Table 1 The reaction of 3-acryloyloxazolidin-2-one (6) and cyclopentadiene (7) catalyzed by ligand (S,S)-5 complexed to
various metal salts in CH2Cl2 at room temperature.
Entry Metal salt Time/min Yield/% Endo:exoa Endo ee/%b Configuration (8)
1 Blank 240 80 96:4 0 –
2 Ca(ClO4)2 45 77 84:16 33 R
3 Zn(ClO4)2 15 75 88:12 40 R
4 Cu(ClO4)2 30 71 86:14 25 R
5 Ni(ClO4)2 120 60 83:17 25 S
6 Mg(ClO4)2 10 85 90:10 72 S
7 Ba(ClO4)2 150 17 80:20 0 –
8 Al(ClO4)3 20 86 83:17 0 –
9 Co(ClO4)2 45 86 86:14 28 S
10 Fe(ClO4)2 15 62 86:14 30 S
11 Mn(ClO4)2 60 78 89:11 36 S
12 Cu(OTf)2 75 55 81:19 7 S
13 Sc(OTf)2 15 62 85:15 5 S
a Determined by 1H NMR.
b Determined by HPLC (Chiralpak IB).
Table 2 Solvent effect on the reaction of 3-acryloyloxazolidin-2-one (6)
and cyclopentadiene (7) catalyzed by ligand (S,S)-5 complexed to
Mg(ClO4)2 at room temperature.
Solvent Time/min Yield/% Endo:exo Endo ee/% Configuration
(8)
DCM 10 85 90:10 72 S
THF 150 87 89:11 2 S
CH3CN 240 80 92:8 14 S
Table 3 Effect of different counterions on reaction of 3-acryloyloxa-
zolidin-2-one (6) and cyclopentadiene (7) catalyzed by ligand (S,S)-5 and
Mg salts in CH2Cl2 at room temperature.
Metal Time/min Yield/% Endo:exo Endo ee/% Configuration
salt (8)
Mg(ClO4)2 10 85 90:10 72 S
MgBr2 240 60 90:10 2 S
MgCl2 150 48 92:8 8 S
Mg(OTf)2 120 73 91:9 17 S
Mg(SbF6)2 30 95 92:8 23 S
Table 4 Effect of different catalytic loadings, additives and temperatures on the reaction of 3-acryloyloxazolidin-2-one (6) and
cyclopentadiene (7) catalyzed by ligand (S,S)-5 complexed to Mg(ClO4)2 in CH2Cl2.
Entry Mol % ligand Temperature/°C Time/min Yield/% Endo:exo a Endo ee/%b
1 1 r.t. 60 80 87:13 25 (S)
2 5 r.t. 45 79 89:11 30 (S)
3 10 c r.t. 15 86 90:10 71 (S)
4 10 r.t. d 87 90:10 72 (S)
5 10 d r.t. 10 86 90:10 72 (S)
6 10 0 30 84 90:10 74 (S)
7 10 –40 e – 98:2 81 (S)
a Determined by 1H NMR.
b Determined by HPLC (Chiralpak IB).
c 4 Å Molecular sieves added.
d Slow addition of cyclopentadiene over 1 h.
e Reaction was too slow and stopped after 24 h , without going to completion (<10% yield).
the chirality of the reaction product.
It appears that ligand 5 is one of very few tridentate N,O,N-
bis(oxazoline)-type ligands reported before.15,35,36
In addition, the calculated energies of these possible complex
structures show that complex A is more energetically favoured
than complex B by 20 kJ mol–1. Upon inspection of the low energy
complex structure it was quite clear that the Re-face of the unsat-
urated bond of the dienophile 6 is much less hindered than the
Si-face (see Fig. 1). This will lead to the (S)-endo product 8. This
theoretical result is consistent with the experimentally observed
absolute configuration and enantiomeric purity of the (S)-endo
product 8 determined by chiral HPLC analysis.
Furthermore, inspection of the HOMO of the computed
complex structure also revealed that the dienophile (oxazo-
lidinone 6) experienced a high level of delocalization (the
cube file of the calculated complex HOMO is available from
kruger@ukzn.ac.za).
A significant level of delocalization would explain the rigidity
of the dienophile, which prevents rotation around the C-1’-C-2’
bond, as indicated above. Oxazolidinone in form 6a will yield
the correct product for pro-S attack while 6b will give the oppo-
site product. Note that cyclopentadiene attacks the alkene 6a
with the CH2 group farthest away from the carbonyl oxygen.
Conclusions
A novel C1 symmetric PCU bis(4-phenyloxazoline) ligand 5
was synthesized and tested on the asymmetric Diels-Alder
reaction between 3-acryloyloxazolidin-2-one (6) and cyclo-
pentadiene (7). The anhydrous magnesium perchlorate complex
emerged as the best catalyst providing the endo-cycloadduct
product 8 of the reaction in 81% enantiomeric excess with an
endo:exo ratio of 98:2. From the molecular modelling of this
magnesium complex with substrate 6, the more energetically
favoured conformation was established which had the Re-face
of the dienophile in a less hindered position. Diels-Alder
cycloaddition of cyclopentadiene to the Re-face leads to a product
consistent with the experimentally observed endo product 8. A
pentacoordinate complex system is observed in the computed
complex structure. The calculated bond length revealed that the
ether oxygen of the PCU moiety acts as a donor atom to the
magnesium ion in the complex. The computational model also
suggests that further modifications on the PCU skeleton will not
affect any asymmetric induction and therefore further study will
focus on the derivatization on the R-group of the oxazoline




All solvents were distilled from the appropriate desiccant.
NMR spectra were recorded on a Bruker (Karlsruhe, Germany)
AVANCE III 400 MHz instrument. Infrared spectra were obtained
on a Perkin-Elmer (Waltham, MA, USA) Spectrum 100 instru-
ment with an attenuated total reflectance (ATR) attachment.
Optical rotations were carried out on a Perkin-Elmer 341
polarimeter. All melting points are uncorrected. Column
chromatography was carried out using silica gel 60. Mass spectra
were measured on a Waters (Milford, MA, USA) LCT Premier
time of flight (TOF) mass spectrometer. HPLC analysis was
carried out with a Shimadzu (Tokyo, Japan) Prominence fitted
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Figure 1 Optimized structures of the ligand-Mg-dienophile complexes [B3LYP/6-31+G(d)].
Figure 2 Simplified scheme of dienophile (6) complexed to Mg(II).
with a LC-2AD pump, SIL-20A autosampler and SPD-M2OA
diode array detector. The type of column and conditions are
described in the appropriate experimental section below.
4.2. 5,5-Dicarboxymethyl-4-oxahexacyclo[5.4.1.02,6.05,10.05,9.08,11]
dodecane (11)9,10
A solution of the diene 10 (5.0 g, 20.3 mmol) in dry methanol
(150 mL) was cooled to –78 °C via application of an external dry
ice–acetone bath and was then purged with nitrogen for 20 min.
Ozone was bubbled into the mixture until a blue-purple colour
persisted, thereby indicating the presence of excess ozone and
completion of the reaction. Excess ozone was flushed from the
reaction vessel with a stream of nitrogen, and the reaction mix-
ture was concentrated in vacuo to yield the ozonide. Hydrogen
peroxide (50 mL, 30%) was added dropwise to a stirred, ice
bath-cooled mixture of the ozonide and formic acid (50 mL,
80%). The resulting mixture was stirred at ambient temperature
for 1 h and then refluxed for 12 h. The reaction mixture was
allowed to cool gradually to ambient temperature, during which
time the product precipitated out of solution. Pure 11 (4.7 g,
82%) was thereby obtained as a colourless microcrystalline
solid: Melting point = 175–175.5 °C. 1H NMR (DMSO) δ = 1.45
(AB, JAB = 10 Hz, 1H), 1.83 (AB, JAB = 10 Hz, 1H), 2.36–2.80 (m,
12H) and 12.15 ppm (br s, 2H); 13C NMR (DMSO) δ = 37.94 (t),




(S) Phenylglycine methyl ester (1.0 g, 4.9 mmol) was added to a
stirred solution of lithium aluminum hydride (0.4 g, 9.8 mmol)
in dry THF (150 mL) at ambient temperature. Thereafter the
solution was refluxed for 1.5 h. The reaction mixture was then
removed from the heat source and allowed to cool, after which
an equal volume of diethyl ether was added. The reaction was
quenched with saturated aqueous Na2SO4 solution. It was
filtered and the solvent removed in vacuo to yield pure amino
alcohol as yellow crystals (0.6 g, 88%). To a solution of the amino
alcohol (3.0 g, 21.7 mmol) in dry CH2Cl2 (150 mL) were added
Et3N (6.3 mL, 44.5 mmol) and DMAP (0.5 g, 4.09 mmol) at room
temperature. The solution was cooled to 0–1 °C and TBDMSiCl
(3.4 g, 27.7 mmol) in CH2Cl2 (20 mL) was added. The solution was
stirred for a further 48 h at room temperature and then H2O
(30 mL) was added. The layers were separated and the aqueous
layer was extracted with CH2Cl2. The combined organic phases
were dried over anhydrous Na2SO4 and the solvent was removed
in vacuo. The resulting residue was purified by column chroma-
tography (CH2Cl2/MeOH = 95:5) to afford product 12 (4.5 g, 83%)
as a yellow oil. 1H NMR (CDCl3) δ = 0.04 (6H, s), 0.91 (9H, s), 1.85
(NH, br s), 3.50 (1H, dd CH2O), 3.72 (1H, dd, CH2O), 4.07 (1H,dd,
CHPh) and 7.40–7.23 ppm (5H, m); 13C NMR (CDCl3) δ = –5.41
(CH3), 18.3 (CH3), 25.9 (C(CH3)3), 57.6 (CHPh), 69.5 (CH2O), 126.9,
127.2, 128.2 and 142.6 ppm (aromatic).
4.4. PCU bis-amide 1311
To a stirred solution of 11 (2.0 g, 7.25 mmol) in dry CH2Cl2
(150 mL), HOBt (2.0 g, 14.6 mmol) and DCC (3.0 g, 14.6 mmol)
were added respectively. This mixture was allowed to stir
for 15 min until a clear homogenous solution was obtained.
Thereafter a mixture of 12 (4.5 g, 18.0 mmol) and Et3N (4.0 mL,
28.9 mmol) in 50 mL dry CH2Cl2 was added and the resulting
mixture was stirred at ambient temperature for a further 12 h.
The reaction mixture was then filtered and H2O added to the
filtrate. The layers were separated and the aqueous layer was
extracted with CH2Cl2. The combined organic phases were dried
over anhydrous Na2SO4 and the solvent was removed in vacuo.
The resulting residue was purified by column chromatography
(hexane/EtOAc = 50:50) to afford compound 13 (4.8 g, 90%) as a
yellow solid. [α]20D –11.35 ° (c = 1 g (100 mL)
–1, CH2Cl2). IR νmax:
3312 cm –1 (s), 1646 cm –1 (vs), 1112 cm –1 (vs) and 776 cm –1 (vs).
Melting point = 126–130 °C. HRMS calculated for C43H62N2O5Si2
(M + H+) 743.4231, found 743.4146. 1H NMR (CDCl3) δ = 0.00 (s),
0.98 (s), 1.65 (d) (AB, JAB = 10.5 Hz), 1.98 (d) (AB, JAB = 10.5 Hz),
2.87 (m), 3.06 (m), 4.05 (m), 5.21 (s) and 7.36–7.52 ppm (aromatic);
13C NMR (CDCl3) δ = –5.60 (t), 18.26 (s), 25.83 (q), 39.91 (t), 41.50
(d), 43.35 (t), 44.28 (d), 48.83 (d), 54.64 (d), 59.11 (d), 66.60 (t), 94.21
(d), 126.92 (d), 127.24 (d), 128.52 (d), 140.36 (s) and 169.2 ppm (s).
4.5. PCU bis-amino alcohol 1411
The PCU bis-amide 13 (5.5 g, 7.41 mmol) was dissolved in dry
THF (200 mL) and TBAF (29.6 mL, 1 mol L–1 in THF) was added.
The mixture was stirred for 48 h at ambient temperature. Brine
was added and the layers were separated. The aqueous layer
was extracted with EtOAc. The combined organic layers were
dried over anhydrous Na2SO4 and the solvents were removed
in vacuo. The resulting residue was purified by column chroma-
tography (EtOAc/MeOH = 95:5) to afford the deprotected
alcohol 14 (3.0 g, 76%) as a pale yellow solid. [α]20D +32.45 ° (c =
1 g (100 mL)–1, CH2Cl2). IR νmax: 3288 cm
–1 (br), 1641 cm–1 (vs),
1039 cm–1 (s) and 706 cm–1 (vs). Melting point 50–60 °C. HRMS
calculated for C31H34N2O5 (M + H
+) 515.2501, found 515.2418.
1H NMR (CDCl3) δ = 1.55 (d) (AB, JAB = 10.5 Hz), 1.90 (d) (AB,
JAB = 10.5 Hz), 2.45 (s), 2.73 (m), 2.82 (m), 3.73 (m), 5.02 (s) and
7.23–7.43 ppm (aromatic); 13C NMR (CDCl3) δ = 39.49 (t), 41.54
(d), 43.48 (t), 44.12 (d), 48.63 (d), 55.23 (d), 59.05 (d), 65.90 (t), 94.14
(d), 126.6 (d), 127.6 (d), 128.6 (d), 139.3 (s) and 170.1 ppm (s).
4.6. PCU bis(4-phenyloxazoline) 511
To a stirred solution of 14 (1.0 g, 1.88 mmol) in dry CH2Cl2
(100 mL), SOCl2 (2.7 mL, 37.5 mmol) was added. The solution
was stirred at ambient temperature for 3 h. The resulting mixture
was poured into H2O and extracted with CH2Cl2. The combined
organic extracts were dried over Na2SO4 and the solvent
removed in vacuo to yield a brown residue of the PCU
bis-chloride 15, which was used without further purification.
The residue was treated with NaOH (1 g in 20 mL H2O) in a
MeOH (50 mL)/CH2Cl2 (30 mL) solution at ambient temperature
for 12 h. The organic solvents were evaporated in vacuo and the
residue was extracted with CH2Cl2. The combined organic
extracts were dried over anhydrous Na2SO4 and the solvents
were removed in vacuo. The resulting residue was purified by
column chromatography (100% EtOAc) to afford the PCU
bis(4-phenyloxazoline) ligand 5 (0.72 g, 80%) as a yellow oil.
[α]20D –57.24 ° (c = 0.85 g (100 mL)
–1, (CH3)2CHOH). IR νmax:
2964 cm–1 (w), 1663 cm–1 (s), 984 cm–1 (s) and 700 cm–1 (vs). HRMS
calculated for C31H30N2O3 (M + H
+) 479.2290, found 479.2350.
1H NMR (CDCl3) δ = 1.55 (d) (AB, JAB = 10.5 Hz), 1.90 (d) (AB,
JAB = 10.5 Hz), 2.45 (s), 2.73 (m), 2.82 (m), 3.73 (m), 5.02 (s) and
7.23–7.43 ppm (aromatic); 13C NMR (CDCl3) δ = 32.11 (t), 41.86
(d), 43.55 (t), 44.64 (d), 48.67 (d), 59.26 (d), 69.66 (d), 74.76 (t), 93.71
(d), 126.5 (d), 127.6 (d), 128.8 (d), 142.3 (s) and 165.9 ppm (s).
4.7. General Procedure for the Diels-Alder Reactions
Catalyzed by the PCU bis (4-phenyloxazoline) Complexes
4.7.1. Preparation of the Anhydrous Magnesium (II) Complex
A mixture of PCU bis (4-phenyloxazoline) 5 ligand (17 mg,
0.04 mmol), anhydrous MgBr2 (6.5 mg, 0.04 mmol), and anhy-
drous AgClO4 (14.7 mg, 0.08 mmol) in dry CH2Cl2 (5 mL) was
stirred under dry nitrogen at ambient temperature for 6 h,
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during which time a gray precipitate of silver bromide appeared.
The resulting suspension was used without filtration for the
Diels-Alder reactions as follows: 3-acryloyl-2-oxazolidinone 6
(50 mg, 0.4 mmol) and freshly distilled cyclopentadiene 7
(0.3 mL, 4.0 mmol) were added to this suspension. The reaction
was performed at room temperature and monitored by TLC.
After the completion of reaction, saturated aqueous ammonium
chloride was added and the mixture was extracted with CH2Cl2.
The combined organic extracts were dried over Na2SO4 and the
solvents were removed in vacuo. The resulting residue was
purified by flash column chromatography (hexane/EtOAc =
70:30) to give a mixture of endo and exo isomers of cycloadduct 8
(60 mg, 85%). The endo:exo ratio was evaluated on the basis of the
1H NMR spectrum and the enantiomeric excess determined by
HPLC with a Daicel Chiralpak IB column (hexane/i-PrOH =
95:5), flow rate = 1 L min–1, t(R) 24.0 min, t(S) 22.6 min. Other
anhydrous PCU bis (4-phenyloxazoline) complexes were
prepared according to a similar procedure by using anhydrous




Colourless solid; enantiomeric purity was estimated on the
basis of HPLC using a chiral column as described above and
the endo:exo ratio was evaluated on the basis of the 1H NMR
spectrum; 1H NMR (CDCl3) δ = 1.3–1.7 (3H, m, H-3 and one of
H-7), 1.9–2.1 (1H, m, the other of H-7), 2.94 (1H, m, H-1 or H-4),
3.31 (1H, m, H-4 or H-1), 3.8–4.1 (3H, m, H-2 and H-4’), 4.40 (2H, t,
H-5’), 5.88 (1H, dd, H-5) and 6.25 ppm (1H, dd, H-6); 13C NMR
(CDCl3) δ = 29.56 (C-3), 42.89, 42.95, 43.21, 46.39 (C-1, C-2, C-4,
and C-4’), 50.18 (C-7), 61.97 (C-5’), 131.63, 138.11 (C-5 and C-6),
153.41 (C-2’), and 174.75 ppm (CO).
4.9. Computational Details
Complexes A and B were optimized using GAUSSIAN 03,39
utilizing density functional theory (DFT) in the gas phase with
the B3LYP functional and with the 6-31+(G)d basis set. Diffuse
functions are typically used for a more accurate description
where lone pair electrons are involved, while polarization
functions remove some limitations of the basis set by expansion
of the virtual space. Solvation effects were not considered in
order to simplify the model. Cartesian coordinates of the opti-
mized structures are available as Supplementary Material
online. A number of variations of the starting geometry were
explored, but it was quite clear that the rigid nature of the
complexes revert to the same low energy structures.
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